Overview
Diagu provides an AI tool for doctors in primary care, clinics and hospitals that collects patient histories, organizes symptoms and test results, and assesses case urgency. It transcribes consultations and prepares clinical documentation, patient summaries and reports for the doctor to review.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 91 days late).
- 202515/07/2026
- 202426/05/2025
- 202315/07/2024
- 202211/07/2023
- 202114/10/2022
- 202015/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Medical software
- Medical triage
- Visit transcriptions
- Clinical documentation
- Test result analysis
- Patient reports
Website technology
- Website
- Nuxt
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by a member of the management board. In the case of a multi-member management board, representation of the company requires joint action of the President of the Management Board and a member of the management board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 33 | $445.71 | 23.4043% | |
Anna Marta Rybka Krysiakage 40 | 108 | $1,458.67 | 76.5957% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2020-08-04.
89 1050 1520 1000 0090 3223 4347
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 28, 2022 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,509$2,509 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Oct 15, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $3,345$3,345 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości | |
| Jun 26, 2020 | Aid for SME access to finance — aid for start-ups | $205.1K$205,139 | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2025-05-05 | Development of an AI system for diagnosing diseases and personalizing treatment, which will use patient medical data to generate personalized reports for treating physicians | $1.1M$1,087,789 | European Funds for a Modern Economy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Infomed Softwaresp. z o.o. | $460,781.60 | infomed-software.pl | ||
| Diagnova Technologiessp. z o.o. | $445,925.86 | diagnova.pl | ||
| Medchartsp. z o.o. | $326,843.22 | medchart.pl | ||
| IQ Medsp. z o.o. | $301,729.42 | iq-med.pl | ||
| Medsisp. z o.o. | $282,594.01 | medsi.pl | ||
| Riget Softwaresp. z o.o. | $265,827.10 | riget.pl | ||
| Aproco.IoP.S.A. | $253,398.32 | aproco.io | ||
| Webetsp. z o.o. | $233,627.01 | webet.pl | ||
| Arhatsp. z o.o. | $157,124.10 | arhat.com.pl | ||
| His-Solutionssp. z o.o. | $90,321.80 | his-solutions.pl |
Change history
| Date | Event | |
|---|---|---|
| 2023-08-23 | Share capital increase (6,250.00 PLN → 7,050.00 PLN) | |
| 2020-12-30 | Share capital increase (5,000.00 PLN → 6,250.00 PLN) | |
| 2020-06-18 | Entered in the register |
FAQ
Last updated: 2026-07-30